Atlas Trials

Stereotactic Prostate Radiotherapy With Dose Escalation Focused on the "Dominant Intra-prostatic Lesion" (DIPL) Delineated by Multi-parametric MRI and 68Ga-PSMA PET (Prostate-SIB-PSMA)

Clinical trial NCT05599737 · UNKNOWN

Trial details

NCT number
NCT05599737
Sponsor
Centre Leon Berard
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate Adenocarcinoma
Start date
2022-05-24
Primary completion
2024-05-25
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.